Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond A Swanson

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
Biomolecules|March 29, 2023
Use of Botulinum Toxin for Limb Immobilization for Rehabilitation in Rats with Experimental StrokeHongxia Zhang, Jialing Liu, Deborah Bingham, et al.
The Journal of Biological Chemistry|February 11, 2004
Alternative, nonapoptotic programmed cell death: mediation by arrestin 2, ERK2, and Nur77Susana Castro-Obregón, Rammohan V Rao, Gabriel del Rio, et al.
Progress in Neurobiology|May 5, 2021
α-synuclein aggregates induce c-Abl activation and dopaminergic neuronal loss by a feed-forward redox stress mechanismSoumitra Ghosh, Seok Joon Won, Jiejie Wang, et al.
Journal of Neuroinflammation|July 27, 2012
Recurrent/moderate hypoglycemia induces hippocampal dendritic injury, microglial activation, and cognitive impairment in diabetic ratsSeok Joon Won, Byung Hoon Yoo, Tiina M Kauppinen, et al.
Journal of Neuroinflammation|October 29, 2025
Transcriptional and neuroprotective effects of hexokinase-2 inhibitors administered after strokeSeok Joon Won, Gӧkhan Uruk, Nguyen Mai, et al.
Journal of Neurotrauma|December 30, 2017
Effects of Veliparib on Microglial Activation and Functional Outcomes after Traumatic Brain Injury in the Rat and PigKaren-Amanda Irvine, Robin K Bishop, Seok Joon Won, et al.
Cell Death & Disease|April 13, 2024
α-Synuclein triggers cofilin pathology and dendritic spine impairment via a PrP<sup>C</sup>-CCR5 dependent pathwayMarina I Oliveira da Silva, Miguel Santejo, Isaac W Babcock, et al.
British Journal of Pharmacology|February 19, 2017
Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseasesNathan A Berger, Valerie C Besson, A Hamid Boulares, et al.
Journal of Neurochemistry|January 6, 2024
Brain energy metabolism: A roadmap for future researchCaroline D Rae, Joseph A Baur, Karin Borges, et al.
Nature Immunology|October 17, 2018
Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegenerationJae Kyu Ryu, Victoria A Rafalski, Anke Meyer-Franke, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Biomolecules|March 29, 2023
Use of Botulinum Toxin for Limb Immobilization for Rehabilitation in Rats with Experimental StrokeHongxia Zhang, Jialing Liu, Deborah Bingham, et al.
The Journal of Biological Chemistry|February 11, 2004
Alternative, nonapoptotic programmed cell death: mediation by arrestin 2, ERK2, and Nur77Susana Castro-Obregón, Rammohan V Rao, Gabriel del Rio, et al.
Progress in Neurobiology|May 5, 2021
α-synuclein aggregates induce c-Abl activation and dopaminergic neuronal loss by a feed-forward redox stress mechanismSoumitra Ghosh, Seok Joon Won, Jiejie Wang, et al.
Journal of Neuroinflammation|July 27, 2012
Recurrent/moderate hypoglycemia induces hippocampal dendritic injury, microglial activation, and cognitive impairment in diabetic ratsSeok Joon Won, Byung Hoon Yoo, Tiina M Kauppinen, et al.
Journal of Neuroinflammation|October 29, 2025
Transcriptional and neuroprotective effects of hexokinase-2 inhibitors administered after strokeSeok Joon Won, Gӧkhan Uruk, Nguyen Mai, et al.
Journal of Neurotrauma|December 30, 2017
Effects of Veliparib on Microglial Activation and Functional Outcomes after Traumatic Brain Injury in the Rat and PigKaren-Amanda Irvine, Robin K Bishop, Seok Joon Won, et al.
Cell Death & Disease|April 13, 2024
α-Synuclein triggers cofilin pathology and dendritic spine impairment via a PrP<sup>C</sup>-CCR5 dependent pathwayMarina I Oliveira da Silva, Miguel Santejo, Isaac W Babcock, et al.
British Journal of Pharmacology|February 19, 2017
Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseasesNathan A Berger, Valerie C Besson, A Hamid Boulares, et al.
Journal of Neurochemistry|January 6, 2024
Brain energy metabolism: A roadmap for future researchCaroline D Rae, Joseph A Baur, Karin Borges, et al.
Nature Immunology|October 17, 2018
Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegenerationJae Kyu Ryu, Victoria A Rafalski, Anke Meyer-Franke, et al.
Pageof 13